Research

volunteer hands 2

New Research: Prevalence of Alopecia Areata across Races and Ethnicities

Does alopecia areata (AA) affect all races and ethnic groups equally? If yes, why is this important? Knowing AA prevalence…

New Clinical Trial Data Published for Ritlecitinib

Results from a clinical trial for a new treatment for alopecia areata were published in the medical journal The Lancet…

Treatment Development Program Impact Report

As we come to the close of 2022, we look upon these past 12 months as among the most pivotal…

Recent Survey Study Results

When you participate in a survey that comes to you in a NAAF email, what happens to your responses? For…

FDA Accepts Filing of New Drug Application (NDA)

Today we received the welcome news that the U.S. Food and Drug Administration (FDA) accepted for filing the New Drug…

FDA Approves Olumiant™ (baricitinib) for Adults with Severe Alopecia Areata

Today, history was made as the U.S. Food and Drug Administration (FDA) approved Olumiant™ for alopecia areata, marking the first…